Our Esteemed Speakers

We are honored to welcome a distinguished panel of speakers who are pioneers in the field of toxicologic pathology, oncology research, and pharmaceutical sciences. With decades of experience spanning academia, regulatory agencies, and leading pharmaceutical companies, these experts bring a wealth of knowledge that is both deep and rare. Each speaker has significantly contributed to the advancement of science through groundbreaking research, regulatory leadership, and global collaborations.


Their insights, drawn from real-world experience and cutting-edge innovation, promise to enrich our understanding of oncology and toxicology in ways few can. This is not just a lineup of professionals — it's a gathering of minds shaping the future of medicine.

Conference Speakers (Day 1 - Nov 7)

Dr. Gabriele

Pohlmeyer-Esch

DVM, Dipl. ECVP - Director of Pathology at Boehringer Ingelheim Pharma, Germany with 30+ years of experience in toxicologic pathology

Conference Topic

The Concept of Adversity in Anatomic Toxicologic Pathology

View More

Dr. Lindsay Tomlinson

DVM, DVSc – Senior veterinary pathologist with 23+ years in toxicologic pathology at Pfizer and Bristol-Myers Squibb.

Conference Topic

Biomarkers of Adversity

View More

Dr. Sibylle Groeters

Dipl. ECVP – Vice President and Senior Executive Expert in Toxicology at BASF SE, Germany, with 20+ years of experience in toxicologic pathology.

Conference Topic

Adversity Considerations in Relation to the Agrichemical Industry

View More

Dr. Renee Hukkanen

DVM, MS, Diplomate ACVP – Director of Pathology at Amgen, Inc. with experience in toxicologic pathology across pharma, chemical, and regulatory sectors.

Conference Topic

NOAEL and Adversity Assessment in Oncology Drug Development

View More

Dr. Sunish Mohanan

BVSc, MS, PhD, Diplomate ACVP – Senior Director of Research Pathobiology at Gilead Sciences with expertise in oncology, immunotoxicology, and drug safety.

Conference Topic

Immune System Adversity: Challenges and Insights in Toxicologic Pathology

View More

Dr. Brian W. Soper

PhD - Senior Scientific Engagement Manager, The Jackson Laboratory, USADr.; expert in humanized mouse platforms and immune modulation.

Conference Topic

Human HSC & PBMC Platforms for In Vivo Immune Modulatory Drug Discovery

View More

Dr. Klaus Weber

DVM, PhD, MSBiol, DJSTP –
Founder, AnaPath Services GmbH, Switzerland Expert in toxicologic and human pathology with 25+ years’ experience. Specializes in neuropathology, inhalation path-ology, and oncogenicity studies.

Conference Topic

Innovations and Challenges in Neuropathology for Nonclinical Toxicology Studies

View More

Conference Speakers (Day 2 - Nov 8)

Dr. Ken Frazier

DVM, PhD – Experimental nephrologist and retired toxicologic pathologist from GSK; expert in drug-induced kidney injury.

Conference Topic

Renal Toxicity Associated with Novel Therapeutics

View More

Dr. Shim-mo Hayashi

DVM, PhD – Fellow at Japan’s National Institute of Health Sciences and Visiting Professor at Tokyo University of Agriculture and Technology, expert in food safety and toxicologic pathology.

Conference Topic

Health Foods and Risk Assessment: Regulatory and Safety Aspects

View More

Dr. Deepa Rao

BVSc, MS, PhD, DABT, DACVP – Consulting veterinary pathologist at Greenfield Pathology Services with deep expertise in neurotoxicology and regulatory toxicologic pathology.

Conference Topic

Drug-Induced Sensory Neuropathy: Getting Aligned to Detect & Trans-late Neurotoxicity

View More

Dr. Padma Kumar

Narayanan

BVSc, MS, PhD – Vice President and Head of Preclinical & Clinical Development Sciences at Wave Life Sciences, specializing in RNA thera-peutics and immunotoxicology.

Conference Topic

Nonclinical Safety Assessment of Novel Oligonucleotide Therapies Intended for CNS Delivery

View More

(IATP Maronpot Guest Lecture)

Dr. Bhanu Pratap Singh

BVSc, MS, DACVP, DABT, FIATP

Senior Director, Nonclinical Safety and Pathobiology, Gilead Sciences Inc, USA

Conference Topic

Developing Long-Acting Injectable (LAIs): Non-Clinical Strategies and Considerations for Local Tolerability in Animal Models

View More

Dr. Alok Sharma

BVSc, MVSc, MS, PhD, DACVP, DABT Director, Global Anatomic Pathology at Labcorp, with specialization in nervous system toxicologic pathology and direct CNS delivery studies.

Conference Topic

Direct CNS Delivery of Non-traditional Modalities: Navigating Technical Aspects and Pathology

View More

Conference Speakers (Day 3 - Nov 9)

Dr. Kuldeep Singh

BVSc, MS, PhD, Diplomate ACVP -Head of Pathology at Wave Life Sciences, specializing in toxicologic and investigative pathology with extensive experience in oligo-nucleotide therapeutics.

Conference Topic

Preclinical Safety Findings Asso-ciated with Systemically Admi-nistered Oligonucleotides (ASOs and siRNAs) and Strategies to Adjudicate Them

View More

Dr. Dinesh Bangari

BVSc, MVSc, PhD – Senior Director, Global Pathology, Pfizer Inc., USA -Expert in discovery toxicology and advanced in-vitro systems with a focus on integrating AI/ML in pathology workflows.

Conference Topic

New Advanced Methodologies (Organoids, Organ-on-Chips, etc.) in Discovery Toxicology and AI/ML in Pathology

View More

Tijo Thomas

Head of Software Development at AIRA MATRIX, specializing in AI/ML-powered digital pathology and preclinical image analysis solutions.

Conference Topic

Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI

View More

Dr. Taishi Shimazaki

DVM, DJCVP, DJSTP, DJSOT – Pathologist at Japan Tobacco Inc., specializing in toxicologic pathology and AI-driven image analysis.

Conference Topic

Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI

View More

Dr. Ramesh Subbarayan

MVSc, PhD – Research Director, In-vivo Pharmacology at Syngene International, specializing in preclinical drug discovery.

Conference Topic

Streamlining Preclinical Workflows: Fast Track Approach for Development and Integration of Digital Pathology and AI

View More

Dr. Lars Siim Madsen

PhD – Chief Scientific Officer at Ellegaard Göttingen Minipigs with 25 years of experience in immunology, molecular biology, and biotech leadership.

Conference Topic

Göttingen Minipigs in R&D: Foundations, Applications, and Future Potential in Nonclinical Safety Assessment

View More

Dr. Venkatesha Udupa

MVSc, MSc, PhD, ERT, DABT, DSP - Senior Vice President and Head of Toxicology at Glenmark Pharmaceuticals, with over 28 years of expertise in nonclinical safety, pathology, and regulatory toxicology.

Conference Topic

Species-Specific Responses to Non-CAD Metabolite M2: Insights into Phospholipidosis and Toxicity

View More

Dr. Henglei Lu

PhD - Pathology Manager at Shanghai Institute of Materia Medica and Vice President of CPA-STP and CCVP.

Conference Topic

Introduction to Stem Cell Therapy Products and Nonclinical Safety Assessment in China

View More

Dr. Wan-Seob Cho

DVM, PhD – Professor of Veterinary Pathology at Dong-A University; expert in nanomaterial and particle toxicology.

Conference Topic

Assessment of Inhalation Toxicology and Pathology of Ultrafine Particles (UFPs) in Rats

View More

Dr. Masami Suzuki

DVM, PhD - President, The Japanese Society of Toxicologic Pathology

Head, Translational Research Division, Central Institute for Expe-rimental Medicine and Life Science

Conference Topic

Japanese Society of Toxicologic Pathology: Current Status and Future Prospects & rasH2-Tg Mouse: Development History and Production/Monitoring System

View More

SUBSCRIBE TO OUR NEWSLETTER

STP-I

Contact us

+91 95383 70426 | +91 63521 83618

stpiconference2025@gmail.com

stpi.india@gmail.com

Get Socially connected

Society of Toxicologic Pathology, 29, 1st Cross, Malleshwaram, Bengaluru, Karnataka 560003

Privacy Policy

Terms of use

Made in India

Our Esteemed Speakers

We are honored to welcome a distinguished panel of speakers who are pioneers in the field of toxicologic pathology, oncology research, and pharmaceutical sciences. With decades of experience spanning academia, regulatory agencies, and leading pharmaceutical companies, these experts bring a wealth of knowledge that is both deep and rare. Each speaker has significantly contributed to the advancement of science through groundbreaking research, regulatory leadership, and global collaborations.

Their insights, drawn from real-world experience and cutting-edge innovation, promise to enrich our understanding of oncology and toxicology in ways few can. This is not just a lineup of professionals — it's a gathering of minds shaping the future of medicine.

(Day 1 - Nov 7)

(Day 2 - Nov 8)

(Day 3 - Nov 9)

SUBSCRIBE TO OUR NEWSLETTER

STP-I

Contact us

+91 95383 70426

+91 63521 83618

stpi.india@gmail.com

stpiconference2025@gmail.com

Get Socially connected

Society of Toxicologic Pathology, 29, 1st Cross, Malleshwaram, Bengaluru, Karnataka 560003

Privacy Policy

Terms of use

Made in Bharat

SUBSCRIBE TO OUR NEWSLETTER

STP-I

Contact us

+91 95383 70426

+91 63521 83618

stpi.india@gmail.com

stpiconference2025@gmail.com

Get Socially connected

Society of Toxicologic Pathology, 29, 1st Cross, Malleshwaram, Bengaluru, Karnataka 560003

Privacy Policy

Terms of use

Made in Bharat